Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas. 2021

Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.

Uterine smooth muscle tumors of uncertain malignant potential (STUMPs) represent a heterogeneous group of tumors that cannot be histologically diagnosed as unequivocally benign or malignant. For this reason, many authors are working to obtain a better definition of diagnostic and prognostic criteria. In this work, we analyzed the genomic and epigenomic profile of uterine smooth muscle tumors (USMTs) in order to find similarities and differences between STUMPs, leiomyosarcomas (LMSs) and leiomyomas (LMs), and possibly identify prognostic factors in this group of tumors. Array-CGH data on 23 USMTs demonstrated the presence of a more similar genomic profile between STUMPs and LMSs. Some genes, such as PRKDC and PUM2, with a potential prognostic value, were never previously associated with STUMP. The methylation data appears to be very promising, especially with regards to the divergent profile found in the sample that relapsed, characterized by an overall CGI hypomethylation. Finally, the Gene Ontology analysis highlighted some cancer genes that could play a pivotal role in the unexpected aggressive behavior that can be found in some of these tumors. These genes could prove to be prognostic markers in the future.

UI MeSH Term Description Entries
D007889 Leiomyoma A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues. Fibroid,Fibroid Tumor,Fibroid Uterus,Fibroids, Uterine,Fibroma, Uterine,Fibromyoma,Leiomyoma, Uterine,Fibroid Tumors,Fibroid, Uterine,Fibroids,Fibromas, Uterine,Fibromyomas,Leiomyomas,Tumor, Fibroid,Tumors, Fibroid,Uterine Fibroid,Uterine Fibroids,Uterine Fibroma,Uterine Fibromas,Uterus, Fibroid
D007890 Leiomyosarcoma A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865) Leiomyosarcoma, Epithelioid,Leiomyosarcoma, Myxoid,Epithelioid Leiomyosarcoma,Epithelioid Leiomyosarcomas,Leiomyosarcomas,Leiomyosarcomas, Epithelioid,Leiomyosarcomas, Myxoid,Myxoid Leiomyosarcoma,Myxoid Leiomyosarcomas
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
November 2004, Acta obstetricia et gynecologica Scandinavica,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
August 2020, European journal of obstetrics, gynecology, and reproductive biology,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
December 2011, Best practice & research. Clinical obstetrics & gynaecology,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
June 1994, Obstetrics and gynecology,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
June 1992, American journal of obstetrics and gynecology,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
January 2011, European journal of gynaecological oncology,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
December 2004, Journal of magnetic resonance imaging : JMRI,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
March 1988, Nihon Sanka Fujinka Gakkai zasshi,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
October 2011, International journal of clinical oncology,
Donatella Conconi, and Serena Redaelli, and Andrea Alberto Lissoni, and Chiara Cilibrasi, and Patrizia Perego, and Eugenio Gautiero, and Elena Sala, and Mariachiara Paderno, and Leda Dalprà, and Fabio Landoni, and Marialuisa Lavitrano, and Gaia Roversi, and Angela Bentivegna
January 2019, Arkhiv patologii,
Copied contents to your clipboard!